Europe Pharmacogenomics Market

Europe Pharmacogenomics Market size was valued at USD 9.6 billion in 2025 and is forecast to grow from USD 10.5 billion in 2026 to reach USD 16.3 billion by 2031, at a CAGR of 11.2%.

Description

The Europe Pharmacogenomics Market size was valued at USD 9.6 billion in 2025 and is forecast to grow from USD 10.5 billion in 2026 to reach USD 16.3 billion by 2031, at a CAGR of 11.2%. Pharmacogenomics encompasses sequencing platforms, microarray technologies, polymerase chain reaction assays, and bioinformatics tools used to analyze genetic variants that influence individual drug response, metabolism, and efficacy, ranging from clinical genotyping services to advanced whole-genome sequencing performed in diagnostic laboratories and research institutes. The market sits at the intersection of genomics, precision medicine, and clinical pharmacology, making it one of the most strategically important enabling categories across the regional personalized healthcare and diagnostics value chain.

Demand for pharmacogenomics products and services remains anchored by rising adoption of precision prescribing protocols, growing recognition of adverse drug reaction prevention benefits, and expanding clinical integration of genetic testing across Germany, France, the United Kingdom, and the Netherlands. Beyond oncology applications, pharmacogenomics continues to enable personalized dosing in cardiovascular medicine, psychiatry, infectious disease treatment, and pain management that require accurate, clinically validated genetic insights. Increasing reimbursement coverage for pharmacogenomic testing, expanding electronic health record integration, and continued bioinformatics platform development are sustaining consumption even as the region transitions toward more systematic, population-scale pharmacogenomics implementation frameworks.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology (Sequencing, Microarray, Polymerase Chain Reaction, Others)

      2. By Application (Oncology, Cardiovascular Diseases, Infectious Diseases, Psychiatry & Neurology, Others)

      3. By End User (Home Care Settings, Hospitals & Clinics, Diagnostic Laboratories, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

      4. By Region

  • Netherlands Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

      4. By Region

  • United Kingdom Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

      4. By Region

  • France Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

      4. By Region

  • Spain Pharmacogenomics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Technology

      2. By Application

      3. By End User

      4. By Region

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Pharmacogenomics Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Illumina Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Thermo Fisher Scientific Inc.

    3. F. Hoffmann-La Roche Ltd.

    4. Bio-Rad Laboratories Inc.

    5. Myriad Genetics Inc.

    6. Agilent Technologies Inc.

    7. Genoptix Inc.

    8. OPKO Health Inc.

    9. PGRx Inc.

    10. GeneMind Biosciences Company Ltd.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology